BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9339867)

  • 1. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
    Coppola G; Pascotto A
    Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine in typical absence epilepsy.
    Buoni S; Grosso S; Fois A
    Brain Dev; 1999 Jul; 21(5):303-6. PubMed ID: 10413016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
    Grisotto KP; Bruck I; Antoniuk SA; Santos LH
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine--a clinical overview.
    Wallace SJ
    Seizure; 1994 Dec; 3 Suppl A():47-51. PubMed ID: 7894852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
    Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
    Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Guo CY; Ronen GM; Atkinson SA
    Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
    Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
    J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.